{"id":415130,"date":"2021-01-14T10:38:30","date_gmt":"2021-01-14T15:38:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=415130"},"modified":"2021-01-14T10:38:30","modified_gmt":"2021-01-14T15:38:30","slug":"tauriga-sciences-inc-completes-payment-for-the-entirety-of-its-initial-production-run-of-its-caffeine-infused-version-of-tauri-gum","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tauriga-sciences-inc-completes-payment-for-the-entirety-of-its-initial-production-run-of-its-caffeine-infused-version-of-tauri-gum\/","title":{"rendered":"Tauriga Sciences Inc. Completes Payment for the Entirety of its Initial Production Run of its Caffeine Infused Version of Tauri-Gum"},"content":{"rendered":"
\n

\n \n <\/p>\n

This Caffeine Version of Tauri-Gum\u2122 is the 7th<\/sup>\u00a0\u00a0SKU of this Fast-Growing Product Line\u00a0<\/p>\n

NEW YORK, NY, Jan. 14, 2021 (GLOBE NEWSWIRE) — \u00a0via NewMediaWire<\/u><\/a>— Tauriga Sciences, Inc. (OTCQB:\u00a0TAUG) (\u201cTauriga\u201d or the \u201cCompany\u201d), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as an ongoing Pharmaceutical Development initiative, has today announced that it has completed payment for the entirety of its initial production run of its caffeine infused version of Tauri-Gum\u2122.\u00a0After extensive research, the Company has decided to infuse each piece chewing gum with 50mg of caffeine.\u00a0\u00a0This product will be manufactured in the flavor of CHERRY LIME RICKEY and the MSRP, per Blister Pack, is expected to be set at $9.99 each.\u00a0\u00a0The Company expects that this initial production run will yield approximately 9,000 Blister Packs (900 Retail Display Boxes).\u00a0\u00a0Availability:\u00a0\u00a0This caffeine infused version of Tauri-Gum\u2122 will be available on the Company E-Commerce website (www.taurigum.com<\/a>), later this Quarter.\u00a0\u00a0\u00a0\u00a0<\/p>\n

The Company believes that the completed production run of this 7th<\/sup>\u00a0\u00a0SKU of Tauri-Gum\u2122, has the potential to drive additional revenue growth.\u00a0\u00a0In addition to E-Commerce business, the Company will now have 2 distinct Tauri-Gum\u2122 SKUs (which contain no Cannabinoids) \u2013 to present to major retailers.\u00a0\u00a0Additionally, with air travel being substantially reduced, a high-quality Caffeine chewing gum may be of interest to those driving extended distances.<\/p>\n

In other news, the Company continues to realize important levels of progress with respect to a number of different corporate initiatives.\u00a0\u00a0The Company expects to disclose to shareholders one or more material Agreement(s) \/ Partnership(s), within the near term.<\/p>\n

\n ABOUT TAURIGA SCIENCES INC.<\/b>\n <\/p>\n

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.\u00a0\u00a0The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (\u201cCBD\u201d) and Cannabigerol (\u201cCBG\u201d) Edibles market segment.\u00a0\u00a0The main product line, branded as Tauri-Gum\u2122, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum\u2122 Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum\u2122 Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc \u201cImmune Booster\u201d Flavor: Pear Bellini).\u00a0\u00a0The Company\u2019s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at\u00a0http:\/\/www.tauriga.com<\/p>\n

Complementary to the Company\u2019s retail business, is its ongoing Pharmaceutical Development initiative.\u00a0 This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum\u2122, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 18, 2020, the Company announced that it had filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum\u2122.\u00a0 The Patent, filed with the U.S.P.T.O. is Titled \u201cMEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT\u201d.\u00a0 On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company’s clinical development efforts.<\/p>\n

On October 6, 2020, the Company announced that it has been approved to operate as a U.S. Government Vendor (CAGE CODE # 8QXV4)<\/p>\n

The Company is headquartered in Wappingers Falls, New York.\u00a0\u00a0In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.<\/p>\n

\n DISCLAIMER — Forward-Looking Statements<\/b>\n <\/p>\n

This press release contains certain \u201cforward-looking statements\u201d as defined by the Private Securities Litigation Reform Act of 1995 which represent management\u2019s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as \u201cmay,\u201d \u201cwill,\u201d \u201cexpects,\u201d \u201canticipates,\u201d believes, \u201chopes,\u201d \u201cbelieves,\u201d or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management\u2019s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in\u00a0\u00a0forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the \u201cRisk Factors\u201d section of Tauriga\u2019s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.<\/p>\n

\n Contact:<\/b>\n <\/p>\n

Tauriga Sciences, Inc.<\/p>\n

4 Nancy Court, Suite 4<\/p>\n

Wappingers Falls, NY 12590<\/p>\n

Chief Executive Officer<\/p>\n

Mr. Seth M. Shaw<\/p>\n

Email:\u00a0sshaw@tauriga.com<\/p>\n

cell # (917) 796 9926<\/p>\n

Company Instagram: @taurigum<\/p>\n

Personal Instagram:\u00a0@sethsms47<\/p>\n

Twitter: @SethMShaw<\/p>\n

Corp. Website:\u00a0\u00a0\u00a0www.tauriga.com<\/a><\/p>\n

E-Commerce Website:\u00a0\u00a0www.taurigum.com<\/a><\/p>\n

\n Attachment<\/strong>\n <\/p>\n